← FDA DRUG APPROVALS

FDA ANDA · ANDA200691

PHENYTOIN

Sponsor: RISING

APPLICATION
ANDA200691
TYPE
ANDA
ORIGINAL APPROVAL
2012-12-26
LATEST ACTION
2024-09-27
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Prescription

Products

PHENYTOINPrescription
PHENYTOIN 50MG · TABLET, CHEWABLE · ORAL

Approval history

2024-09-27Labeling · Supplement 7 · standardAP
2024-09-27Labeling · Supplement 5 · standardAP
2024-09-27Labeling · Supplement 11 · standardAP
2024-09-27Labeling · Supplement 8 · standardAP
2017-01-06Labeling · Supplement 2 · standardAP
2017-01-06Labeling · Supplement 3 · standardAP
2012-12-26Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →